Table 3 Comparison of neoadjuvant hormonal therapy on the outcome of laparoscopic radical prostatectomy
From: Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy
References | Period of NHT* (months) | No. of patients | Transfusion rate (%) | PSM** rate (%) | BCR*** rate after 2 years (%) |
|---|---|---|---|---|---|
Rassweiler et al. [14] | |||||
 NHT group | NA | 42 | 46.0 | NA | NA |
 non-NHT group | - | 138 | NA | NA | NA |
Gregori et al. [15] | |||||
 NHT group | less than 3 | 21 | NA | NA | NA |
 non-NHT group | - | 59 | NA | NA | NA |
Brown et al. [7] | |||||
 NHT group | less than 3 | 5 | 0 | 0 | NA |
 non-NHT group | - | 60 | 1.7 | 17.0 | NA |
Maldonado-Valadez et al. [16] | |||||
 NHT group | 3.5 | 50 | 36.0 | 18.0 | NA |
 non-NHT group | - | 50 | 52.0 | 16.0 | NA |
Pu et al. [6] | |||||
 NHT group | 3 | 25 | 32.0 | 12.0 | NA |
| Â | 8 | 19 | 31.2 | 10.5 | NA |
 non-NHT group | - | 11 | 36.4 | 45.5 | NA |
Our series | |||||
 NHT group | 3 or less | 47 | 2.12 | 27.7 | 27.7 |
| Â | more than 3 | 25 | 4.00 | 28.0 | 4.00 |
 non-NHT group | - | 270 | 1.48 | 42.2 | 17.8 |